medical marijuana israel

Read More
Less
A worker touches a cannabis plant at a growing facility for the Tikun Olam company near the northern

Cannabis can reduce COVID-19 complications, mitigate fibrosis - study

A study found that 3 of the strains tested were able to inhibit cytokine storms and mitigate future risks of developing pulmonary fibrosis.

Israeli cannabis oil 'espresso machine' start-up smashes funding goal

The company says it is only months from launching its product in Israel and plans to enter the US market next year.

Israeli company developing medical cannabis spray to treat skin conditions

The innovative topical spray is expected to effectively treat atopic dermatitis, psoriasis, pain and lesions.

Israeli cannabis, tobacco use has risen sharply during COVID-19 - survey

Over 1 in 5 Israelis have refrained or delayed medical treatment for fear of catching the disease.

Could cannabis help minimize post-surgery opioid addiction?

The current widely accepted treatment for acute pain involves a mix between highly-addictive opioids and other pain relief drugs.

First commercial medical cannabis export from Israel lands in Germany

Germany is home to the fastest-growing medical cannabis market outside the US.

Together Pharma secures NIS 10m. loan from Bank Mizrahi-Tafahot

Together currently operates two medical cannabis greenhouses in Israel and Uganda and is able to produce roughly 30 tons annually.

Workers at Intelicanna's facility sort through products.

Cannabis industry prepares for Israeli legalization

Recreational market expected to rake in billions of dollars; CBD-infused cosmetics and food also set to hit supermarket shelves

By MAYA MARGIT/THE MEDIA LINE
17/12/2020

Israeli medical cannabis approved for export to Germany, France

Only last month, Panaxia became the first Israeli medical cannabis company receive a commercial export license.

Israel's first commercial medical cannabis export lands in Australia

While Israel first approved medical cannabis exports almost two years ago, issues with Ya'acov Litzman's 2017 reform have caused the process to stall

Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use and privacy policy